Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04047550 · ClinicalTrials.gov registry record
Respiratory Control and Narcotic Effects
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 10
- Enrollment target
NCT04047550 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 10 participants.
The verdict
NCT04047550 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The aim of this study is to provide data that will assess the role of ventilatory chemosensitivity (respiratory drive) in determining postoperative respiratory depression due to opioids. In a group of patients requiring surgery and admission to hospital, before surgery, ventilatory chemosensitivity will be assessed in the presence or absence of an infusion of remifentanil. Parameters will be correlated with ventilatory depression events after surgery. A secondary aim is to determine whether respiratory depression is more likely during specific phases of sleep.
Interventions
- DIAGNOSTIC_TEST Ventilatory chemosensitivity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-03-08 |
| Est. Completion | 2019-02-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04047550
The ClinicalTrials.gov registry entry for NCT04047550 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ventilatory chemosensitivity is the first listed.
NCT04047550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04047550 about?
NCT04047550 is a clinical study titled "Respiratory Control and Narcotic Effects". The aim of this study is to provide data that will assess the role of ventilatory chemosensitivity (respiratory drive) in determining postoperative respiratory depression due to opioids. In a group of patients requiring surgery and admission to hospital, before surgery, ventilatory chemosensitivity ...
What is the current status of trial NCT04047550?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2018-03-08. Estimated completion is 2019-02-09.
What interventions are being tested in trial NCT04047550?
The interventions under investigation include: Ventilatory chemosensitivity (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04047550?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.